Differentiation of High-Quality hPSCs Using STEMdiff™ and TeSR™-AOF
In this COREdinates Focus Session from ISSCR 2022, Kim Snyder reviews data generated by hPSCs maintained in TeSR™-AOF and their compatibility with STEMdiff™ differentiation protocols.
Publish Date:
July 29, 2022
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
TeSR™-AOF: Designing a Product for the Future
Publish Date: July 28, 2021 -
STEMdiff™: Products for Differentiating Human Pluripotent Stem Cells
Publish Date: June 27, 2011 -
Maintaining and Assessing High-Quality hPSC Cultures
Publish Date: March 12, 2018
Explore Our Products
-
STEMdiff™ Hematopoietic - EB Supplement A
Animal component-free culture supplement for mesoderm specification with downstream lymphoid potential -
STEMdiff™ Ventricular Cardiomyocyte Differentiation Kit
Serum-free media for differentiation of human PSCs to ventricular cardiomyocytes and long-term maintenance of human PSC-derived cardiomyocytes -
Animal origin-free suspension culture medium for human ES and iPS cells -
For expansion and differentiation of hPSCs to NK cells
